6.83
price down icon2.57%   -0.18
after-market Handel nachbörslich: 6.83
loading

Finanzdaten der Unicycive Therapeutics Inc-Aktie (UNCY)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.44%
7.342
6.963 7.989 9.261 6.251
Operating Income/Loss
5.44%
-7.342
-6.963 -7.989 -9.261 -6.251
Nonoperating Income/Loss
157.95%
1.331
0.516 8.559 -12.26 2.155
Income/Loss From Continuing Operations Before Tax
6.76%
-6.011
-6.447 0.57 -21.52 -4.096
Income/Loss From Continuing Operations After Tax
6.76%
-6.011
-6.447 0.57 -21.52 -4.096
Net Income/Loss
6.76%
-6.011
-6.447 0.57 -21.52 -4.096
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
46.85%
18.07
12.30 116.82 12.91 88.94
Diluted Average Shares
46.85%
18.07
12.30 123.83 12.91 88.94
Basic Earnings Per Share
36.54%
-0.33
-0.52 0.03 -0.26 -0.05
Diluted Earnings Per Share
36.54%
-0.33
-0.52 -0.05 -0.26 -0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):